Australia markets closed

Innate Pharma S.A. (0EVI.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
3.02810.0000 (0.00%)
At close: 05:19PM GMT
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 35.30%
S&P500 52-week change 329.57%
52-week high 33.7800
52-week low 31.9947
50-day moving average 32.8338
200-day moving average 32.7034

Share statistics

Avg vol (3-month) 33.73k
Avg vol (10-day) 34.95k
Shares outstanding 557.58M
Implied shares outstanding 6N/A
Float 830.48M
% held by insiders 124.68%
% held by institutions 19.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -12.28%
Operating margin (ttm)-57.22%

Management effectiveness

Return on assets (ttm)-4.04%
Return on equity (ttm)-14.28%

Income statement

Revenue (ttm)61.64M
Revenue per share (ttm)0.77
Quarterly revenue growth (yoy)77.50%
Gross profit (ttm)N/A
EBITDA -7.58M
Net income avi to common (ttm)-7.57M
Diluted EPS (ttm)-0.6640
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)92.46M
Total cash per share (mrq)1.15
Total debt (mrq)39.89M
Total debt/equity (mrq)76.86%
Current ratio (mrq)3.73
Book value per share (mrq)0.64

Cash flow statement

Operating cash flow (ttm)-32.56M
Levered free cash flow (ttm)-27.81M